Ciclesonide and Formoterol interaction

Ciclesonide and Formoterol: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Formoterol (FORMOTEROL FUMARATE) label · effective 2020-12-15

Major

Use of a LABA, including formoterol fumarate inhalation solution, without an inhaled corticosteroid is contraindicated in patients with asthma [see Warnings and Precautions (5.1) ].

Contraindicationsby drug classView label on DailyMed
Major

• Use of a LABA, including formoterol fumarate inhalation solution, without an inhaled corticosteroid is contraindicated in patients with asthma.

Contraindicationsby drug classView label on DailyMed
Major

• Use of long-acting beta 2 -adrenergic agonists (LABA) as monotherapy [without inhaled corticosteroids (ICS)] for asthma is associated with an increased risk of asthma-related death.

Warnings and precautionsby drug classView label on DailyMed
Moderate

• LABA as monotherapy (without inhaled corticosteroid) for asthma increases the risk of serious asthma-related events.

Warnings and precautionsby drug classView label on DailyMed
Moderate

• Xanthine derivatives, steroids, diuretics, or non-potassium sparing diuretics may potentiate hypokalemia or ECG changes.

Drug interactionsby drug classView label on DailyMed

From the Ciclesonide (Alvesco) label · effective 2025-02-28

Moderate

Patients should be instructed to contact their physician immediately if episodes of asthma not responsive to their usual doses of bronchodilators occur during the course of treatment with ALVESCO.

Warnings and precautionsby drug classView label on DailyMed
Moderate

Lung function (FEV 1 or AM PEFR), beta-agonist use, and asthma symptoms should be carefully monitored during withdrawal of oral corticosteroids.

Warnings and precautionsby drug classView label on DailyMed
Minor

Acute Asthma Episodes ALVESCO is not a bronchodilator and is not indicated for rapid relief of bronchospasm or other acute episodes of asthma.

Warnings and precautionsby drug classView label on DailyMed
Minor

If bronchospasm occurs following dosing with ALVESCO, it should be treated immediately with a fast-acting inhaled bronchodilator.

Warnings and precautionsby drug classView label on DailyMed
No interaction

In clinical studies, concurrent administration of ciclesonide and other drugs commonly used in the treatment of asthma (albuterol, formoterol) had no effect on pharmacokinetics of des-ciclesonide [see Clinical Pharmacology ( 12.3 )] .

Drug interactionsnames FormoterolView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.